Gorka Etxebarria, new Chief Scientific Officer of Nostrum Biodiscovery Blog Post

Nostrum Biodiscovery (NBD) has appointed Dr. Gorka Etxebarria as new Chief Scientific Officer. Dr Etxebarria has a solid career linked to drug discovery projects in the pharmaceutical industry. His incorporation comes after the signing of Ezequiel Mas as new company CEO, to pilot a new stage of growth as a global provider of leading molecular simulation technologies applied to drug discovery and design.

 

Oncoheroes Biosciences and the Super Sam Foundation walking together for the pediatric cancer Blog Post

Oncoheroes Biosciences announces the receipt of funding from Super Sam Foundation, a pediatric cancer nonprofit organization. Oncoheroes is a Boston based biotech with its European headquarters at the Barcelona Science Park. The startup was co-founded in 2017 by Ricardo Garcia, a serial entrepreneur from Barcelona, and the Italian scientist Cesare Spadoni, two parents touched by childhood cancer and determined to change the outlook for these young patients.

 

IESE opens a new call for Proposals for the Barcelona Technology Transfer Group Blog Post

IESE Business School opens their 7th Edition of the program of the Barcelona Technology Transfer Group (BTTG), a collaboration program between MBA students and successful mentors with scientists, technologist and entrepreneurs of public and private centres, with the intention of helping create a company or boost their first stages of development. Barcelona Science Park collaborates in this initiative within the strategic agreement set on last January with IESE to promote and support the growth of business initiatives of life sciences.

Droplite opens seed round of 600.000€ to accelerate the manufacturing development of its smart medical diagnostics device Blog Post

Droplite, located in the Parc Cientific de Barcelona (PCB), has recently started the industrial design and manufacturing development of its smart diagnostics device, focused on point of care (POC). The company, that it was born in 2018, as a spinoff of the Institute of Photonics Sciences (ICFO), from the hand of two entrepreneurs: André Guedes (CEO) and Rafael Porcar (CTO), was recognized with the Seal of Excellence by the European Union and with the Innovative SME seal from the Ministry of Science and Innovation.

 

The FDA licenses Chemotargets CLARITY platform Blog Post

Chemotargets –a global leader in the development of intelligence platforms and drug design prediction, headquartered in the Barcelona Science Park– has signed a license agreement for its CLARITY® platform with the Food and Drug Administration (FDA) to provide adverse event predictions and mechanistic investigation in public health risk assessments of new drug applications and existing marketed products.

 

Barcelona Science Park announces a new artistic intervention contest to decorate an outdoor space Blog Post

Barcelona Science Park (PCB) announces a new artistic intervention contest to promote the interaction between art and science. The public and anonymous event offers the opportunity to create, with total thematic freedom, a mural in an outdoor space of 4.5 metres of height per 6.5 metres of width in the Clúster II building, in a junction of various areas of the park at different levels.

 

Juan Carlos Kaski, new Chief Medical Officer of GlyCardial Diagnostics Blog Post

GlyCardial Diagnostics, based in the Barcelona Science Park, announces the appointment of Prof. Juan Carlos Kaski as Chief Medical Officer. The company –a spinoff of the Research Institute of the Hospital de la Santa Creu i Sant Pau (IR-HSCSP) and the Spanish National Research Council (CSIC), is conducting a clinical trial to validate the performance of Apo J-Glyc as a novel biomarker for the early detection of Myocardial Ischaemia.